A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2

Zhi Chen(Shenzhen University), Han Zhang(Southern University of Science and Technology), Taojian Fan(Shenzhen University), S. Wageh(King Abdulaziz University), Yabin Hao(Chinese Academy of Sciences), Xiaopeng Ma(Respiratory Clinical Trials), Yaqing He(Shenzhen Center for Disease Control and Prevention), Changle Meng(Shenzhen University), Yuxuan Tang(Shenzhen University), Zhiguang Luo, Shuai Feng(Minzu University of China), Jiangtian Yu(Shenzhen Institute of Information Technology), Omar A. Al‐Hartomy(King Abdulaziz University), Abdullah G. Al‐Sehemi(King Khalid University), Zhongjian Xie(Jinan University), Jingfeng Li(Istituto Officina dei Materiali), Tianzhong Li(Shenzhen Second People's Hospital), Jianlong Kang(Shenzhen University), Defa Li(Shenzhen Children's Hospital), Luxiao Chai(Shenzhen University), Chaozhou Li(Shenzhen University), William J. Liu(Yale University), Yonghong Shao(Shenzhen University)

National Science Review

June 3, 2022

Cited by 539

|The Lancet|2020|12.6k

|Advanced Materials|2017|4.9k

|Materials Today|2018|1.6k

|Small Methods|2017|1.4k

|Small|2016|1.2k

Related Papers